Lords Mark Industries is actively preparing for a public offering, with plans to raise ₹500 crore through an Initial Public Offering (IPO). The company aims to go public in the first half of 2024, pending regulatory approvals . The IPO proceeds will be utilized to bolster its subsidiaries, focusing on the development of medtech products, innovative diagnostic solutions, expansion of its pathology lab network across India, and the export of medical diagnostic products and machines .
Get expert guidance and the best prices for Lords Mark Industries Limited shares. Our team is ready to assist you with your investment journey.
Consensus estimates indicate a potential share price range of ₹160–₹175 for Lords Mark Industries in 2025. This projection is based on anticipated recovery in industrial demand, improved production efficiency, and strategic market expansion initiatives. Key growth drivers include increased automation in manufacturing and potential development of export markets.
The company is seen as a value play in the industrial sector, offering steady demand, but with a defensive tilt due to cyclical exposures. With enhanced production capacities and modernized operations, it is expected to deliver incremental revenue growth over the mid-term. Investors looking for a conservative industrial pick with a focus on operational efficiency may find it appealing.
Overall, it has a moderate risk profile with a defensive orientation once production stabilizes. Cyclical Risk: Vulnerability to economic slowdowns in the manufacturing sector. Commodity Price Risk: Exposure to fluctuations in raw material costs. Operational Risk: Implementation of new technologies may come with initial execution challenges.
Explore the leading Unlisted Shares currently in high demand. Stay informed about the latest Unlisted Share Price trends and make well-informed investment decisions. Our platform provides you with up-to-date information on Share Price movements, helping you navigate the world of unlisted stocks with ease.
